Status:
UNKNOWN
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication
Lead Sponsor:
Wayne State University
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
ICU Patients 18 Years or Older.
Eligibility:
All Genders
18-80 years
Brief Summary
Patients in intensive care units have higher risks for developing blood clots. Arixtra inhibits blood clot formation by binding with the blood clotting factor, Xa. Critical illnesses and, specifically...
Detailed Description
In view of the high risk of venous thrombolism (VTE) in critically ill patients, it is essential for all ICUs to develop a standardized approach to thromboprophylaxis. Several studies in a critical se...
Eligibility Criteria
Inclusion
- ICU patients 18 or over, weight 50 kg or more in the ICU will be enrollment eligible. Pregnant women and those with neuraxial anesthesia, renal or liver problems, or BMI over 40 are not eligible.
Exclusion
- Patients under 18, weight less than 50 kg, pregnant women and those with neuraxial anesthesia, renal or liver problems, or BMI over 40 are not eligible.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
End Date :
January 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00424281
Start Date
February 1 2007
End Date
January 1 2010
Last Update
January 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harper University Hospital, ICU
Detroit, Michigan, United States, 48201